Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working Group.
Vaccines (Basel)
; 10(4)2022 Mar 22.
Article
in En
| MEDLINE
| ID: mdl-35455238
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Vaccines (Basel)
Year:
2022
Type:
Article
Affiliation country:
United States